<VariationArchive RecordType="classified" VariationID="1805110" VariationName="NM_005901.6(SMAD2):c.748_754del (p.Ser250fs)" VariationType="Deletion" Accession="VCV001805110" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862125" VariationID="1805110">
      <GeneList>
        <Gene Symbol="SMAD2" FullName="SMAD family member 2" GeneID="4087" HGNC_ID="HGNC:6768" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="47808957" stop="47930872" display_start="47808957" display_stop="47930872" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="45359465" stop="45457516" display_start="45359465" display_stop="45457516" Strand="-" />
          </Location>
          <OMIM>601366</OMIM>
          <Haploinsufficiency last_evaluated="2018-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005901.6(SMAD2):c.748_754del (p.Ser250fs)</Name>
      <CanonicalSPDI>NC_000018.10:47851303:TAGGAGATAG:TAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="47851304" stop="47851310" display_start="47851304" display_stop="47851310" variantLength="7" positionVCF="47851303" referenceAlleleVCF="GTAGGAGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="45377675" stop="45377681" display_start="45377675" display_stop="45377681" variantLength="7" positionVCF="45377674" referenceAlleleVCF="GTAGGAGA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>S220fs</ProteinChange>
      <ProteinChange>S250fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.47851307_47851313del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.47851307_47851313del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.45377678_45377684del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.45377678_45377684del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029946.1" sequenceAccession="NG_029946" sequenceVersion="1" change="g.84835_84841del">
            <Expression>NG_029946.1:g.84835_84841del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029946.2" sequenceAccession="NG_029946" sequenceVersion="2" change="g.84562_84568del">
            <Expression>NG_029946.2:g.84562_84568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001003652.4" sequenceAccession="NM_001003652" sequenceVersion="4" change="c.748_754del">
            <Expression>NM_001003652.4:c.748_754del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001003652.1" sequenceAccession="NP_001003652" sequenceVersion="1" change="p.Ser250fs">
            <Expression>NP_001003652.1:p.Ser250fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135937.3" sequenceAccession="NM_001135937" sequenceVersion="3" change="c.658_664del">
            <Expression>NM_001135937.3:c.658_664del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129409.1" sequenceAccession="NP_001129409" sequenceVersion="1" change="p.Ser220fs">
            <Expression>NP_001129409.1:p.Ser220fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005901.6" sequenceAccession="NM_005901" sequenceVersion="6" change="c.748_754del" MANESelect="true">
            <Expression>NM_005901.6:c.748_754del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005892.1" sequenceAccession="NP_005892" sequenceVersion="1" change="p.Ser250fs">
            <Expression>NP_005892.1:p.Ser250fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005901.6(SMAD2):c.748_754del (p.Ser250fs) AND Loeys-Dietz syndrome 6" Accession="RCV002471528" Version="1">
        <ClassifiedConditionList TraitSetID="71323">
          <ClassifiedCondition DB="MedGen" ID="C5562041">Loeys-Dietz syndrome 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="71323" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61034" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Loeys-Dietz syndrome 6</ElementValue>
                <XRef ID="MONDO:0030500" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LDS6</ElementValue>
                <XRef Type="MIM" ID="619656" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <XRef ID="C5562041" DB="MedGen" />
              <XRef ID="MONDO:0030500" DB="MONDO" />
              <XRef Type="MIM" ID="619656" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5413139" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_005901_5_SMAD2_c_748_754delTCTCCTA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768269" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Loeys-Dietz syndrome 6 (LDS; MIM#619656). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Rare examples of non-penetrance in LDS have been documented, including somatic mosaicism (GeneReviews). (I) 0115 - Variants in this gene are known to have variable expressivity. Intrafamilial variability has been reported in LDS (GeneReviews). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0702 - Other NMD-predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_12522</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005901.5:c.748_754delTCTCCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619656" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5413139" TraitType="Disease" MappingType="XRef" MappingValue="619656" MappingRef="OMIM">
        <MedGen CUI="C5562041" Name="Loeys-Dietz syndrome 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

